ACADIA Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
ACAD ACADIA Pharmaceuticals Inc
JOE St. Joe Co
OMC Omnicom Group Inc
CHDN Churchill Downs Inc
SGTB Kuboo Inc
BBBMX BBH Limited Duration Fund Class N
VICI VICI Properties Inc
DDS Dillard's Inc
ALIN-E Altera Infrastructure LP
AUVGF Australian Vintage Ltd
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

ACADIA Pharmaceuticals Inc. (ACADIA) is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines to address the medical needs in central nervous system disorders. The Company's lead product, NUPLAZID (pimavanserin), is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. ACADIA’s developments are focused on pimavanserin for additional neuropsychiatric conditions, trofinetide for Rett syndrome, ACP-044 for pain management and an early-stage muscarinic receptor program.

Closing Price
$21.07
Day's Change
0.12 (0.57%)
Bid
--
Ask
--
B/A Size
--
Day's High
21.59
Day's Low
20.65
Volume
(Below Average)
Volume:
1,535,984

10-day average volume:
1,738,428
1,535,984
  • Prev Close
    20.95
  • Today's Open
    20.89
  • Day's Range
    20.65-21.59
  • Avg Vol (10-day)
    1.7M
  • Last (time)
    3:59p ET 05/07/21
  • Last (size)
    7
  • 52-Wk Range
    19.20 - 58.72
    LowHigh
  • (07/07/20 - 05/05/21)
    9.74%
  • 79.3%
  • Market Cap
    3.4B
  • Shares Outstanding
    160.2M
  • -1.64
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.7
  • 93.20
  • (% of float 04/15/21)
    5.01

Latest News

May 08, 2021
7:52 pm ET
Globe Newswire
11:10 am ET
Globe Newswire
May 07, 2021
12:26 pm ET
Accesswire
May 06, 2021
7:15 pm ET
Newsfile
4:50 pm ET
Accesswire
1:47 pm ET
Accesswire
1:00 pm ET
Accesswire
12:30 pm ET
Accesswire
11:31 am ET
Globe Newswire
8:52 am ET
Globe Newswire
6:19 am ET
Newsfile
May 05, 2021
6:39 pm ET
Newsfile
5:07 pm ET
Newsfile
4:10 pm ET
BusinessWire
2:50 pm ET
Accesswire
2:31 pm ET
Accesswire
2:02 pm ET
Accesswire
12:15 pm ET
Accesswire
11:42 am ET
Newsfile
May 04, 2021
3:40 pm ET
Accesswire
3:01 pm ET
Accesswire
2:46 pm ET
Accesswire
2:00 pm ET
Accesswire
11:30 am ET
Accesswire
11:15 am ET
PR Newswire
11:02 am ET
Accesswire
9:00 am ET
BusinessWire
May 03, 2021
10:32 pm ET
Accesswire
9:52 pm ET
Globe Newswire
3:37 pm ET
Newsfile
1:31 pm ET
Accesswire
6:30 am ET
Accesswire
May 02, 2021
10:42 pm ET
PR Newswire
10:42 pm ET
PR Newswire
May 01, 2021
7:41 am ET
Accesswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.